- Home
- ACH vs MBOT Comparison
ACH vs MBOT Comparison
Compare ACH & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACH | MBOT |
|---|---|---|
| Founded | 1882 | 2010 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.3M | 145.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ACH | MBOT |
|---|---|---|
| Price | $2.37 | $2.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $7.50 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.84 | $1.25 |
| 52 Week High | $2.80 | $4.62 |
Technical Indicators
Market Signals| Indicator | ACH | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 61.57 | 55.50 |
| Support Level | $2.17 | $2.03 |
| Resistance Level | $2.52 | $2.37 |
| Average True Range (ATR) | 0.20 | 0.16 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 85.71 | 64.92 |
Price Performance
Historical ComparisonAbout ACH Accendra Health Inc.
Accendra Health Inc is a world-wide healthcare solutions company providing essential products, services and technology solutions that support care delivery in hospitals, health systems and research centers around the world.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.